期刊文献+

血液透析类医疗器械的监管现状及使用中存在的问题与原因分析 被引量:4

Monitoring Status, Existing Problems in Use and Cause Analysis of Hemodialysis Medical Device
下载PDF
导出
摘要 伴随临床医疗技术的发展,血液透析类医疗器械在各大医院得到较为广泛的应用,对于很多慢性肾衰竭患者具有重要意义。但临床使用过程中,血液透析设备并非完全安全,存在一定的风险性,有的血液透析设备质量不达标,有的重要技术指标未符合标准等现象出现。在对血液透析类医疗器械进行监管过程中,存在检验标准及技术规范的缺失、血液透析器械检测参数指标标准缺失的情况,通过《医疗机构血液透析室管理规范》的实施,虽然解决了一部分临床应用中的问题,但医疗器械管理的内容并无健全性,需进一步的规范研究。在血液透析器械使用过程中,其安全隐患、器械自身问题均需予以关注,了解血液透析器械故障原因,并建立对应解决策略具有重要意义。针对上述问题,应制定有效的医疗器械使用技术规范,提高监管力度,该文研究了血液透析设备安全性管理系统的开发应用,便于逐步避免恶性医疗事件的发生。 With the development of clinical medical technique, the hemodialysis medical device has been widely applied in each big hospital, which is of major significance to many patients with chronic renal failure. The hemodialysis device is not totally safe in the clinical use with a certain risk, the quality of some hemodialysis devices is nonstandard and some major technical indexes fail to meet the standards. The lack of test standards and technical specification and test parameter index standard of hemodialysis device exists in the course of monitoring the hemodialysis medical device, part of clinical applica-tion problems are solved by the implementation of management specification of medical institution hemodialysis room, but the medical device management content is not perfect, which needs further standard research. The hidden danger and device problems need to be paid attention to in the course of using hemodialysis medical device, knowing hemodialysis medical device disorder causes and building countermeasures are of major significance. We should make an effective medical device use technical specification and improve monitoring force aiming at the above problems. The paper researches the develop-ment and application of hemodialysis device safety management system in order to gradually avoid the occurrence of malig-nant medical accidents.
作者 周子人
出处 《中国卫生产业》 2016年第14期110-112,共3页 China Health Industry
关键词 血液透析 医疗器械 监管 问题 原因 Hemodialysis Medical device Monitoring Problem Cause
  • 相关文献

参考文献3

二级参考文献26

  • 1王质刚.应当重视血液透析中看不见的事件[J].中国血液净化,2004,3(10):523-525. 被引量:8
  • 2陈江华.提高血液透析患者长期生存率所面临的挑战[J].中华肾脏病杂志,2006,22(3):133-134. 被引量:80
  • 3顾成雄.风险管理在医院医疗器械管理中的应用[J].中国医疗器械杂志,2007,31(3):222-224. 被引量:28
  • 4林菊英.医院管理学护理管理分册[M].人民卫生出版社,2003.16.
  • 5杨立春,刘京京,张彤.专家:肾病是沉默杀手[N].生命时报.http://health.sohu.com/20070319/n248777563.shtml.
  • 6A.D.Ookalkar.Quality improvement in haemodialysis process using FMEA[J].International Journal of Quality &Reliability Management,2009,26(8):817-830.
  • 7http://news.xinhuanet.com/ newscenter/2009-03/30/content_l1102472.htm.
  • 8http://law.cyol.com/content/2009-12/1/ content_2981410.htm.
  • 9国家食品药品监督管理局,《关于开展体外循环管道类产品再评价工作的通知》(国食药监械(2007)314号).2007年6月1日.Accessed at http://www.cmde.org.cn/CL0104/323.html.
  • 10http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfMAUDE/search.CFM.

共引文献30

同被引文献26

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部